| Patient | Fyodor Dostoevsky |
|---|---|
| Date of birth | 1821-11-11 |
| Identifiers | MRN HR-NI018-SYN-TD; SSN (made up) 000-18-3907 |
| Document date | 1865-07-07 |
| Author | Agnes Lindahl, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Four-month review of seizure control, mood, and gambling recovery. [S]
Mr. Dostoevsky returns four months after starting lamotrigine. He has had no seizure since the one in the third week of the titration, about sixteen weeks ago, including during the stomach illness last month, when he missed two doses. He has no side effects. He has not gambled for five months, although urges came back when an advance from his publisher arrived; he called his therapist and a friend instead. He has finished twelve therapy sessions and now goes every two weeks, and he attends Gamblers Anonymous most weeks. The debt repayment plan has started. He is planning a long research trip abroad in late summer. His mood is good. [S]
| Element | Detail |
|---|---|
| Seizures | None for about sixteen weeks |
| Lamotrigine | 100 mg twice daily; no side effects; two doses missed during the stomach illness |
| Gambling | None for five months; urges handled with his coping plan |
| Plans | A long trip abroad in late summer |
| System | Result | Finding |
|---|---|---|
| Neurological | Negative | No seizures, dizziness, double vision, or unsteadiness |
| Integumentary | Negative | No rash |
| Psychiatric | Negative | Mood good; occasional urges; no thoughts of suicide or self-harm |
3 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Lamotrigine 25 mg tablets, slow titration: 25 mg once daily for weeks 1 and 2, 50 mg once daily for weeks 3 and 4, 50 mg twice daily for week 5, and 75 mg twice daily for week 6 | 25 mg once daily, increased every two weeks and then weekly as written, to 75 mg twice daily in week 6 | Oral route | 1865-03-03 to 1865-04-13 | completed | S |
| Lamotrigine 100 mg tablet, one tablet twice daily | 100 mg twice daily (200 mg a day), 30-day supply at a time | Oral route | 1865-04-14 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1865-07-07 | Body height | 170 | cm | S |
| 1865-07-07 | Body weight | 68.6 | kg | S |
| 1865-07-07 | Body mass index (BMI) [Ratio] | 23.7 | kg/m2 | S |
| 1865-07-07 | Systolic blood pressure | 120 | mm[Hg] | S |
| 1865-07-07 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1865-07-07 | Heart rate | 70 | /min | S |
| 1865-07-07 | Respiratory rate | 14 | /min | S |
| 1865-07-07 | Body temperature | 36.6 | Cel | S |
| 1865-07-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1865-07-07 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S |
Vital signs recorded on 1865-07-07; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; weight 68.6 kg; blood pressure 120/78, heart rate 70 |
| Neurological | No nystagmus or ataxia |
| Psychiatric | Euthymic and future-oriented |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Epilepsy of unknown type with recurrent generalized tonic-clonic seizures of unknown onset, untreated for many years; etiology unknown | active | confirmed | G40.909 | S — Synthetic modern coding of his documented epilepsy. The seizure type is left as unknown onset under the ILAE classification, because the retrospective classifications are disputed; no focal or generalized syndrome is coded. |
| Gambling disorder (roulette, in person and online), moderate, with debts | active | confirmed | F63.0 | S — Synthetic modern coding of his documented compulsive roulette gambling. |
| Acute viral gastroenteritis with vomiting and two missed lamotrigine doses, without dehydration needing intravenous fluids; resolved | resolved | confirmed | A08.4 | S — Synthetic intercurrent illness at an unscheduled visit, chosen to teach missed antiseizure doses during vomiting; it does not echo a documented illness. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Seizure frequency, seizure diary, and seizure description | Every visit | Completed today | No seizure for about sixteen weeks |
| Medication safety | Antiseizure medicine adverse effects (dizziness, double vision, unsteadiness, sleep, mood) | Every visit | Completed today | None |
| Medication safety | Rash and mouth-sore check (lamotrigine) | Every contact during titration and the first two months, then with symptoms | Not indicated | Past the first two months without rash; asked only about symptoms |
| Medication safety | Adherence and missed doses | Every visit | Completed today | Two doses missed during the stomach illness last month; none otherwise |
| Laboratory | Lamotrigine trough level | Once at steady state as a reference, then with breakthrough seizures, suspected nonadherence, or interacting medicines | Up to date | Reference level 6.2 ug/mL two months ago; no new indication |
| Self-management | Trigger review: sleep loss, alcohol, overwork, missed doses | Every visit | Completed today | Sleeping seven hours; travel and time-zone changes discussed as new risks |
| Self-management | Seizure safety and driving counseling | At diagnosis and every visit | Completed today | Not driving; precautions followed; travel safety discussed |
| Self-management | SUDEP discussion | At diagnosis and when seizure control changes | Up to date | Discussed with neurology four months ago; control has improved |
| Survey | Depression screen (PHQ-9) | At intake, then every two to four months while symptoms are present | Completed today | PHQ-9 5, item 9 scored 0 |
| Survey | Suicide-risk review and safety plan, with the 988 Suicide & Crisis Lifeline | Every visit (gambling disorder and antiseizure-medicine labeling) | Completed today | No thoughts of suicide |
| Survey | Gambling since the last visit: days, money lost, and urges (G-SAS for the past week) | Every visit | Completed today | No gambling for five months; G-SAS 8 for the past week |
| Self-management | Cognitive behavioral therapy for gambling disorder | Weekly sessions for at least 8 to 12 weeks, then as needed | Completed today | Twelve weekly sessions completed; now every two weeks; telehealth to be booked for the trip |
| Self-management | Self-exclusion from casinos and online gambling | At the start of treatment; renew and extend after any lapse | Up to date | In place at home; does not cover casinos abroad |
| Self-management | Financial safeguards (bank gambling block, co-signer for large withdrawals, limited cash) | At the start of treatment | Up to date | Bank block and co-signer in place; set cash amount agreed for the trip |
| Referral | Peer support (Gamblers Anonymous) | Offered at the start of treatment and after any lapse | Up to date | Attends most weeks |
| Referral | Debt counseling | Once, early in treatment | Up to date | Repayment plan started |
| Medication safety | Medicine for gambling disorder (opioid antagonist) | Considered if psychological treatment alone is not enough | Not indicated | Responding to psychological treatment |
| Referral | Neurology review | In January, or sooner after a breakthrough seizure | Up to date | Next review in January |
Goal progress:
Guideline basis: Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2015); Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy (2018); Psychological therapies for pathological and problem gambling (2012); Gambling disorder (2019); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)
Follow-up: Eight-month review after his trip. Call or message from abroad after any seizure. Next scheduled visit 1865-10-06: eight-month review after a breakthrough seizure and a gambling lapse while traveling. [S]